Long-COVID post-viral chronic fatigue syndrome and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study.

The immune-inflammatory response during the acute phase of COVID-19, as assessed using peak body temperature (PBT) and peripheral oxygen saturation (SpO2), predicts the severity of chronic fatigue, depression and anxiety (physio-affective) symptoms three to four months later. The present study was performed to characterize whether the effects of SpO2 and PBT on the physio-affective phenome of Long COVID are mediated by immune, oxidative and nitrosative stress (IO&NS) pathways. This study assayed SpO2 and PBT during acute COVID-19, and C-reactive protein (CRP), malondialdehyde (MDA), protein carbonyls (PCs), myeloperoxidase (MPO), nitric oxide (NO), zinc, and glutathione peroxidase (Gpx) in 120 Long COVID individuals and 36 controls. Cluster analysis showed that 31.7% of the Long COVID patients had severe abnormalities in SpO2, body temperature, increased oxidative toxicity (OSTOX) and lowered antioxidant defenses (ANTIOX), and increased total Hamilton Depression (HAMD) and Anxiety (HAMA) and Fibromylagia-Fatigue (FF) scores. Around 60% of the variance in the physio-affective phenome of Long COVID (a factor extracted from HAMD, HAMA and FF scores) was explained by OSTOX/ANTIOX ratio, PBT and SpO2. Increased PBT predicted increased CRP and lowered ANTIOX and zinc levels, while lowered SpO2 predicted lowered Gpx and increased NO production. Both PBT and SpO2 strongly predict OSTOX/ATIOX during Long COVID. In conclusion, the impact of acute COVID-19 on the physio-affective symptoms of Long COVID is partly mediated by OSTOX/ANTIOX, especially lowered Gpx and zinc, increased MPO and NO production and lipid peroxidation-associated aldehyde formation. Post-viral physio-affective symptoms have an inflammatory origin and are partly mediated by neuro-oxidative toxicity.

Following the acute phase of COVID-19, the presence of more than one symptom is quite prevalent, occurring in 74% 11,12 to 87.4 percent of all infected patients 12 . Initially, patient concerns were dismissed as mental health problems, including worry or stress 13 , but later it became clear that people who suffer from longterm COVID have a wide range of physical and mental symptoms [14][15][16] . Among the various symptoms associated with Long COVID, the most frequently reported symptoms are fatigue and dyspnoea 9,11,17,18 , post-traumatic stress symptoms 19, 20 , concentration and memory problems 21,22 , and anxiety and depression 4, 23 . Within six months after the first COVID-19 symptom, almost a third of COVID-19 survivors had a neuropsychiatric diagnosis such as insomnia, anxiety and depression 24 . feelings of guilt, suicidal ideation, loss of interest), key anxiety (anxious mood, tension, fears, anxiety behavior at interview), chronic fatigue and physiosomatic symptoms including autonomic and gastrointestinal (GIS) symptoms, malaise and muscle pain.
Additionally, in both the acute phase and Long COVID, a single latent vector could be derived from these physiosomatic and affective symptoms, demonstrating that these symptom profiles are the expression of a shared core, namely the COVID-19 and Long COVID "physio-affective phenome" 25, 26 .
We reported that in acute COVID-19, the physio-affective phenome was largely predicted by a latent factor derived from indicants of increased proinflammatory and immunoregulatory cytokines, chest computerized tomography scan abnormalities (CCTAs), including ground-glass opacities, crazy patterns and consolidation and lower oxygen saturation in peripheral blood (SpO2) 25 . Importantly, lowered SpO2 and increased peak body temperature during the acute phase of illness largely predict the severity of the physio-affective phenome of Long COVID 26 . Both lowered SpO2 26 and increased peak body temperature 27 are indicants of the severity of the immuneinflammatory response of acute COVID-19, and both predict critical disease and mortality 27, 28 . Therefore, our findings indicate that the infectious-immuneinflammatory pathways during the acute phase of illness 29 largely predict the physioaffective core of Long COVID 26 . Nevertheless, there are no data on whether the biomarkers underpinning Long COVID are caused by the inflammatory responses during the acute phase.
Activated immune-inflammatory and oxidative and nitrosative stress (IO&NS) pathways may underpin the physio-affective symptoms of Long COVID because chronic fatigue syndrome, major depression and generalized anxiety disorder (GAD) are characterized by activated IO&NS pathways. Thus, these disorders are . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Hence, the present study was performed to delineate whether the effects of SpO2 and peak body temperature on the physio-affective phenome of Long COVID are mediated by IO&NS pathways, including CRP, the OSTOX/ANTIOX ratio and its indicators (MDA, AOPP, carbonyl proteins, NOx, nitrotyrosine, TAC, Gpx or zinc). In addition, the present work employs the precision nomothetic approach 31 to define a . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint Long COVID model which links the acute inflammation of COVID-19 with IO&NS pathways and the physio-affective phenome 3-4 months later. Moreover, we intended to construct an endophenotype class 34 that integrates all those biomarkers with the physio-affective phenome of Long-COVID. These findings are necessary to comprehend the biology of Long COVID and post-viral symptoms in general and may aid in predicting who will develop chronic fatigue syndrome and affective symptoms as a result of COVID-19 and viral infections in general.

Subjects
We employed both a case-control research design (to explore differences between controls and Long COVID) and a retrospective cohort study design (to examine the effects of acute-phase biomarkers on Long COVID symptoms) in the current investigation. We recruited 120 patients in the last three months of 2021 who had at least two symptoms consistent with Long COVID and had previously been diagnosed and treated for acute COVID-19 infection. The patients were diagnosed using the WHO criteria of post-COVID (long COVID) 42 , namely: a) individuals having a history of proven SARS-CoV-2 infection, b) symptoms persisted beyond the acute phase of illness or manifested during recovery from acute COVID-19 infection, c) symptoms lasted at least two months and are present 3-4 months after the onset of COVID-19, and d) patients suffer from at least two symptoms that impair daily functioning including fatigue, memory or concentration problems, shortness of breath, chest pain, persistent cough, difficulty speaking, muscle aches, loss of smell or taste, affective symptoms, cognitive impairment, or fever 42 .
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) coughing, and loss of smell and taste; b) positive reverse transcription real-time polymerase chain reaction findings (rRT-PCR); and c) positive IgM directed to SARS-CoV-2. All patients showed, upon recovery from the acute phase, a negative rRT-PCR result. We selected 36 controls from the same catchment area, who were either staff members or their family or friends. Additionally, we included controls who tested negative for rRT-PCR and exhibited no clinical indications of acute infection, such as dry cough, sore throat, shortness of breath, lack of appetite, flu-like symptoms, fever, night sweats, or chills. Nevertheless, we selected the controls so that about one-third of them had distress or adjustment symptoms as a result of lockdowns and social isolation to account for their confounding effects, which are also seen in Long COVID patients.
Thus, one-third of the controls showed Hamilton Depression Rating Scale (HAMD) 43 values between 7 and 12. COVID patients and controls were excluded if they had a lifetime history of psychiatric axis-1 disorders, including major affective disorders such as major depression and bipolar disorder, dysthymia, generalized anxiety disorder and panic disorder, schizo-affective disorder, schizophrenia, psycho-organic syndrome, and substance use disorders, except tobacco use disorder (TUD). Moreover, we excluded patients and controls who suffered from neurodegenerative and neuroinflammatory . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

Clinical measurements
A senior psychiatrist used a semi-structured interview to collect sociodemographic and clinical data from controls and Long COVID patients three to four months after the acute infectious phase of COVID-19 (mean ±SD duration of illness was 14.68 ±5.31 weeks). Three to four months after the onset of acute COVID-19, a senior psychiatrist assessed the following rating scales: a) the 12-item Fibro-Fatigue (FF) scale to assess Chronic fatigue and fibromyalgia symptoms 45 ; b) the HAMD to assess the severity of depression 43 ; and c) the Hamilton Anxiety Rating Scale (HAMA) 46 to assess the severity of anxiety. Two HAMD subdomain scores were calculated: a) pure depressive symptoms (pure HAMD) as the sum of sad mood + feelings of guilt + . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint suicidal thoughts + loss of interest; and b) physiosomatic HAMD symptoms (Physiosom HAMD) as the sum of somatic anxiety + gastrointestinal (GIS) anxiety + genitourinary anxiety + hypochondriasis. Two HAMA subdomain scores were calculated: a) key anxiety symptoms (Key HAMA), which were defined as anxious mood + tension + fears + anxiety behavior during the interview; and b) physiosomatic HAMA symptoms (Physiosom HAMA), defined as somatic sensory + cardiovascular + GIS + genitourinary + autonomic symptoms (respiratory symptoms were not included in the sum). We calculated a single pure physiosom FF subdomain score as: muscular pain + muscle tension + fatigue + autonomous symptoms + gastrointestinal symptoms + headache + a flu-like malaise (thus excluding the cognitive and affective symptoms).
To construct a composite score reflecting the severity of the physio-affective phenome, we extracted the first factor from the pure FF and pure and physiosom HAMA and HAMD scores, which reflect the physio-affective phenome 25, 26 . Additionally, we constructed z unit-based composite scores indicating autonomic symptoms, sleep problems, fatigue, gastro-intestinal symptoms, and cognitive symptoms using all relevant HAMD, HAMA, and FF items (z transformed). TUD was diagnosed using DSM-5 criteria. We determined the body mass index (BMI) by dividing the body weight in kilograms by the squared height in meters.

Assays
Fasting blood samples were taken in the early morning between 7.30-9.00 a.m. after awakening and before having breakfast. Five milliliters of venous blood samples were drawn and transferred into clean plain tubes. Hemolyzed samples were rejected.
After ten minutes, the clotted blood samples were centrifuged for five minutes at 3000 rpm, and then serum was separated and transported into three new Eppendorf tubes . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint until assay. Serum Gpx, NOx, MPO, MDA, AOPP, TAC, nitrotyrosine, and protein carbonyls were measured using ELISA kits supplied by Nanjing Pars Biochem Co., Ltd. (Nanjing, China). All kits were based on a sandwich technique and showed an inter-assay CV of less than 10%. Zinc in serum was measured spectrophotometrically using a ready for use kit supplied by Agappe Diagnostics Ltd., Cham, Switzerland.
A well-trained paramedical specialist measured SpO2 using an electronic oximeter supplied by Shenzhen Jumper Medical Equipment Co. Ltd., and a digital thermometer was used to assess body temperature (sublingual until the beep). We collected these indicators from patient records and analyzed the lowest SpO2 and peak body temperature values recorded during the acute phase of illness. We created a new indicator based on these two evaluations that represent decreased SpO2 and increased peak body temperature as the z transformation of the latter (z body temperature) -z SpO2 (dubbed the "TO2 index"). We recorded the immunizations received by each participant, namely AstraZeneca, Pfizer, or Sinopharm.

Statistics
Analysis of variance (ANOVA) was performed to determine if there were variations in scale variables across groups, and analysis of contingency tables was employed to determine connections between nominal variables. We used Pearson's product-moment correlation coefficients to examine relationships between ONS biomarkers and SpO2, peak body temperature, and clinical physio-affective . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint assessments. We employed a univariate general linear model (GLM) analysis to characterize the associations between classifications and biomarkers while accounting for confounding factors such as TUD, sex, age, BMI, and education. Additionally, we obtained model-generated estimated marginal means (SE) values and used protected pairwise comparisons between group means using Fisher's least significant difference.
Multiple comparisons were examined using a p-correction for false discovery rate (FDR) 47 . Multiple regression analysis was used to determine the important IO&NS biomarkers or cofounders that predict physio-affective measures. We used an automated stepwise technique with a 0.05 p-value to enter and p=0.06 to remove. We calculated the standardized beta coefficients for each significant explanatory variable using t statistics with exact p-value, as well as the model F statistics and total variance explained (R 2 ). Additionally, we examined multicollinearity using the variance inflation factor and tolerance. We checked for heteroskedasticity using the White and modified Breusch-Pagan tests, and where necessary, we generated parameter estimates with robust errors. The tests were two-tailed, and statistical significance was defined as a p-value of 0.05. Using an effect size of 0.23, a p-value of 0.05, a power of 0.8, and three groups with up to five variables in an analysis of variance, the sample size should be around 151 participants. As a result, we enrolled 156 individuals, 36 controls and 120 Long COVID participants.

The precision nomothetic approach
By integrating biomarker and clinical data, we hoped to create endophenotype classes for Long COVID patients (using cluster analysis) and novel pathway phenotypes (using factor analysis). We conducted two-step cluster analyses on categorical (e.g., diagnosis) and scale variables (e.g., all biomarkers) to define new . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint meaningful clusters of Long COVID patients. When the silhouette measure of cohesiveness and separation was more than 0.4, the cluster solution was deemed satisfactory. We conducted exploratory factor analysis (unweighted least-squares extraction, 25 iterations for convergence) and assessed factorability using the Kaiser-Meier-Olkin (KMO) sample adequacy metric (adequate when >0.7). Additionally, when all loadings on the first factor were greater than 0.6, the variance explained by the first factor was greater than 50.0 percent, and the Cronbach alpha on the variables was greater than 0.7; the first factor was considered a validated latent construct underlying the variables. Canonical correlation analysis (CCA) was used to investigate the associations between two sets of variables, with symptoms three to four months following the acute phase serving as the dependent variable set and both biomarkers of the acute and Long COVID phases as the explanatory variable set. We calculated the variance explained by the canonical variables in both sets, and we accept the canonical sets as an overall measure of the underlying construct when the explained variance is > 0.50 and all canonical loadings are > 0.5. Finally, we also compute the variance explained in the dependent clinical set by the biomarker set. All statistical analyses were conducted using IBM SPSS Windows, version 28.
Smart PLS analysis 48 was utilized to investigate the causal links between the lowest SpO2 and peak body temperature in the acute phase and the physio-affective phenome in Long COVID, whereby the effects of SpO2 and temperature are mediated by IO&NS biomarkers. All input variables were entered as single indicators, while the output variable was a latent vector extracted from pure FF and pure and physiosom HAMD and HAMA values. Complete PLS analysis was performed only when the inner and outer models met predefined quality criteria, namely: a) the output LV has high composite reliability >0.7, Cronbach's alpha >0.7, and rho A >0.8 with an average . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint variance extracted (AVE) > 0.5, b) all LV loadings are > 0.6 at p < 0.001, c) the model fit is < 0.08 in terms of standardized root mean squared residual (SRMR), d) confirmatory tetrad analysis shows that the LV was not incorrectly specified as a reflective model, e) blindfolding shows that the construct's cross-validated redundancy is adequate, and f) the model's prediction ability as evaluated using PLSPredict is adequate. If the model quality data are adequate, we perform a complete PLS pathway analysis using 5000 bootstrap samples and compute the path coefficients with exact pvalue, as well as specific and total indirect (mediated) effects and total effects.

Construction of an endophenotype class based on all biomarkers
To discover new endophenotype classes of Long COVID patients, we used a two-step cluster analysis with the diagnosis (Long COVID versus controls as a category) and the acute COVID-19 biomarkers SpO2 and body temperature and Long COVID biomarkers OSTOX, ANTIOX, OSTOX/ANTIOX and CRP as continuous variables. Nevertheless, the solution without CRP was much better, and, therefore, CRP was deleted from the solution. We found a three-group model with an adequate measure of cohesion and separation of 0.57, namely controls (n=36) and two patient clusters comprising 67 (cluster 1) and 51 (cluster 2) patients, respectively. Table 1 shows the socio-demographic and biomarker data of the three clusters. Cluster 2 patients showed lower SpO2, zinc, Gpx and ANTIOX levels and higher body temperature, OSTOX, OSTOX/ANTIOX, NOx, MPO, MDA and protein carbonyl levels as compared with cluster 1 patients. As such, the Long COVID group is divided into two clusters, one (cluster 2) with highly activated O&NS pathways (LC+O&NS) and one with less severe . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint aberrations (LC). The LC group was differentiated from controls by increased body temperature and CRP and lowered SpO2, Gpx and ANTIOX values. Table 1 demonstrates the socio-demographic data in Long COVID patients divided into LC and LC+O&NS. No significant differences among these study groups were detected in BMI, residency, employment, education, vaccination status, and TUD.
Age was somewhat higher in the LC+O&NS group, and there were more males in the LC+O&NS group than in the LC group. The disease duration was somewhat higher in LC+O&NS as compared with LC. Table 2 shows the results of univariate GLM analysis examining the associations between diagnosis into controls, LC and LC+IO&NS and all clinical scores while controlling for the effects of age, sex, education years, and TUD (entered as covariates). We found that the total FF, HAMD and HAMA, pure FF, and pure and physiosom HAMD and HAMA scores, as well as the autonomic and GIS symptoms, were significantly different between the three classes and increased from controls → LC → LC+O&NS. Sleep disorders, chronic fatigue and cognitive disorders were significantly higher in Long Covid than in controls. Table 3 shows the intercorrelation matrix of the O&NS biomarkers, on the one hand, and SpO2, maximal body temperature, and clinical physio-affective ratings, on the other. OSTOX was significantly associated with SpO2, all physio-affective ratings, except cognitive impairment scores. There was no significant association between OSTOX and body temperature. ANTIOX was inversely correlated with all physioaffective ratings, including cognitive impairments and was positively associated with SpO2. The OSTOX /ANTIOX ratio was significantly associated with all physio-. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint affective scores, SpO2 and body temperature. There were no significant associations between CRP and the OSTOX/ANTIOX measurements. Figure 1 shows the partial regression of the physio-affective phenome score on OSTOX/ANTIOX after adjusting for age, sex, BMI, education and TUD. Table 4 shows the results of multiple regression analyses with physio-affective measurements as dependent variables and O&NS biomarkers and CRP as explanatory variables while allowing for the effects of age, sex, BMI, TUD, education and vaccination types. Regression #1 shows that 25.0% of the variance in the pure HAMD score could be explained by the regression on Gpx and education (inversely associated) and MDA, CRP and carbonyl proteins (positively associated). We found that 23.0% of the variance in the physiosom HAMD score (regression #2) was explained by the cumulative effects of lowered Gpx and zinc, increased NO and CRP and vaccination with AstraZeneca or Pfizer. Regression #3 shows that 13.1% of the variance in pure HAMA is explained by CRP, female sex and AstraZeneca vaccination. In Regression #4, 26.7% of the variance in physiosom HAMA was explained by the regression on CRP and NO (positively) and Gpx (inversely), female sex and vaccination with AstraZeneca or Pfizer. Regression #5 shows that 28.0% of the variance in pure FF was explained by NO, MDA, CRP (positively) and Gpx (inversely). Up to 30.2% of the variance in the severity of the physio-affective phenome score was explained by NO, MDA, CRP (positively), Gpx (inversely), female sex, and vaccination with AstraZeneca or Pfizer.

Prediction of the physio-affective scores by IO&NS biomarkers
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Prediction of physio-affective scores by IO&NS biomarkers, SpO2 and body temperature
We have rerun the analyses shown in Table 4 and include the OSTOX, ANTIOX, OSTOX/ANTOX ratio, SpO2 and body temperature and the results are presented in Table 5. SpO2 was inversely associated with all 6 physio-affective scores (regressions #1 -#6), body temperature was positively associated with all scores, except pure HAMA, while IO&NS biomarkers had significant effects on all scores above and beyond the effects of SpO2 and body temperature (all except pure HAMA). Thus, OSTOX was associated with pure HAMD, NO with physiosom HAMD and HAMA and pure FF, MDA predicted pure FF and OSTOX/ANTIOX predicted the physioaffective phenome. The effects of CRP disappeared after considering the effects of the other explanatory variables.
In this Table, we also examine whether the OSTOX/ANTOX ratio and CRP are predicted by SpO2 and body temperature while allowing for the effects of confounders.
Regressions #7 and 8 display that the OSTOX/ANTIOX ratio was predicted by SpO2 and CRP by body temperature and male sex. Figures 2 and 3 show the partial regressions of the OSTOX/ANTIOX ratio on SpO2 and of CRP on body temperature, respectively (after adjusting for age, sex, BMI, and TUD).

Associations between physio-affective scores and all biomarkers combined
To examine the association between the combined effects of SpO2, body temperature and the biomarkers of Long COVID, we performed two types of analyses: a) Pearson's correlation analyses between the physio-affective score and a new composite score computed as z body temperature -SpO2 + z OSTOXz ANTIOX (dubbed the BTO2ONS index); and b) canonical correlation analyses with the physio-. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint affective scores as dependent variables and SpO2, body temperature and a Long COVID biomarker composite score (z OSTOX + z CRPz ANTIOX, dubbed the ONSCRP index) as explanatory variables. Table 3 shows that the BTO2ONS index was significantly correlated with CRP and with all physio-affective scores in the total study group and the restricted study group of Long COVID patients (except for cognitive disorders). Figure 4 shows the partial regression of the physio-affective score on the BTO2ONS composite score after controlling for age, sex, BMI, education and TUD.

Results of PLS and construction of a new endophenotypic class and a pathway phenotype
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint Figure 5 shows a PLS model that examined whether the effects of SpO2 and body temperature during the acute phase of the physio-affective phenome of Long COVID (a latent vector extracted from the 5 rating scale subdomains) are mediated by IO&NS biomarkers. Therefore, we entered all ONS biomarkers and CRP as single indicators that could be predicted by SpO2 or body temperature, and whereby the ONS biomarkers, the overarching OSTOX/ANTIOX ratio and CRP were allowed to predict the physio-affective phenome, which was entered as a latent vector extracted from pure Based on all variables entered in this model (except sex) and the latent physioaffective score, we have performed a two-step cluster analysis with COVID infection . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint as a categorical variable and all biomarkers as scale variables. Figure 6 shows the features of the formed clusters. We discovered a three-cluster model with an appropriate measure of cohesiveness and separation of 0.52, consisting of a control cluster (n=36), patient cluster 1 (n=82) and patient cluster 2 (n-38). Figure 6 shows a clustered bar graph that was made using the significant indicators in the PLS analysis. Patient cluster 2 is a new endophenotype class of Long COVID characterized by very high body temperature, physio-affective scores, MDA, MPO, protein carbonyls and NO values, and very low SpO2, Gpx, zinc and TAC values as compared with cluster 1 (all p<0.01).

Oxidative stress and immune activation in Long COVID
The current study's first major finding is that a) Long COVID is associated with decreased antioxidant defenses, including Gpx, and a mild inflammatory process; and b) 31.7 percent of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and protein carbonyls). To put it another way, Long COVID is associated with immune-inflammatory processes and decreased antioxidant defenses, while a subgroup of Long COVID patients additionally exhibits increased NO production, oxidative damage to proteins (protein carbonyls) and lipids with increased aldehyde formation (MDA), and immune-oxidative stress response (increased MPO and CRP).
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint Previous research found that between 1.8 and 24.5 percent of Long COVID patients had elevated CRP levels 11,[49][50][51][52] , which were operationalized as >10 mg/L or >2.9 mg/dL. Other authors found that median CRP levels varied between 0.6 and 2.9 mg/L 4, 53-55 . Nevertheless, in the present study, we detected that the patient group with As such, our work demonstrates that the oxidative stress biomarkers during Long COVID are quite similar to those found during the acute phase, except for AOPP, nitrotyrosine and TAC levels, which were altered in acute COVID-19 but not in Long . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Although NO production was enhanced considerably in Long COVID, nitrotyrosine levels were not altered, although increased nitrotyrosine indicates an increase in reactive nitrogen species with increased NO2 binding to tyrosine, thereby forming an immunogenic neoepitope 79 . Nonetheless, future research should explore if the increased NO generation in Long COVID results in nitrosative stress associated with hypernitrosylation (increased NO or nitroso binding), which has a variety of neurotoxic . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint consequences 80 . It is critical to remember that low zinc levels have a wide impact on the immune system 81,82 and that zinc itself may reduce viral replication, including SARS-CoV-2 replication 83 .

Biomarkers of acute COVID-19 predict IO&NS biomarkers of Long COVID
The second major finding of this study is that decreased SpO2 levels during the acute phase of COVID-19 significantly predict oxidative toxicity, increased NO production, and decreased Gpx and antioxidant defenses, whereas increased peak body temperature levels during the acute phase predict increased CRP and decreased zinc and antioxidant levels in Long COVID. As a result, both decreased SpO2 and higher body temperature contribute to Long COVID's increased OSTOX/ANTIOX ratio. COVID-19 individuals who require invasive mechanical breathing, admission to an intensive care unit, or lengthy hospitalization are more likely to sustain long-term tissue . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint damage as a result of persistent symptoms [92][93][94] . As such, it appears that COVID-19 (and other viral infectious diseases) is accompanied by three different inflammatory phases: a) beneficial protective inflammation, which combats the infection and may mount a restorative repair, b) hyperinflammation, which may lead to a cytokine storm and critical disease or even death, and c) non-resolving inflammation resulting in a protracted mild inflammatory state 95 as observed in Long COVID. All in all, our results show that the severity of the infectious-immune-inflammatory response during acute COVID-19 may, at least in part, predict mild inflammation and increased nitrooxidative damage in Long COVID.

IO&NS biomarkers predict the physio-affective phenome of Long COVID
The third and most noteworthy finding of this study is the discovery of a) a pathway phenotype comprising SpO2, body temperature, OSTOX, ANTIOX, CRP and the physio-affective phenome; and b) an endophenotype class of Long COVID patients (31.7%) who show simultaneously severe abnormalities in SpO2 and peak body temperature during acute COVID-19, and an increased OSTOX/ANTIOX ratio, CRP and increased total HAMD, HAMA and FF total and subdomain scores during Long COVID. The changes in the rating scale scores indicate the presence of moderate depression and anxiety symptoms consistent with major depression and generalized anxiety disorder and the presence of a chronic fatigue syndrome (lasting 2-3 months), including chronic fatigue, insomnia, autonomic and gastro-intestinal symptoms, and, to a lesser extent, cognitive impairments. Additionally, approximately 60% of the variance in the severity of the physio-affective phenome is explained by the cumulative effects of decreased SpO2 and increased peak body temperature (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. are common [99][100][101] . Notably, the severity of acute COVID-19 infection affects the development of neuropsychiatric symptoms, with ICU survivors being more likely . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint (56%) than non-ICU survivors to develop a neuropsychiatric condition 24 . Most importantly, the results of our study show that chronic fatigue, depression and anxiety symptoms in Long COVID are all manifestations of the same physio-affective core, which is strongly associated with OSTOX/ANTIOX and inflammatory signs.
There is now evidence that major depression, generalized anxiety disorder and Finally, it is also important to note that vaccinations with AstraZeneca (viral vector, genetically modified virus vaccine) and Pfizer (mRNA vaccine), but not Sinopharm (inactivated virus vaccine), may aggravate the physio-affective phenome . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint and, in particular, the physiosomatic symptoms of the HAMA and HAMD subdomains.
It is known that this type of corona vaccine may cause Long Covid-like symptoms, including anxiety, depression and fatigue, T cell activation, autoimmune responses, increased production of spike protein, and impairments in type 1 interferon signaling 111,112 . Limitations.
This research would have been more interesting if we had also assayed the cytokine network, the NLRP3 inflammasome and biomarkers of hypernitrosylation.

HUMAN AND ANIMAL RIGHTS
The study was conducted according to Iraq and international ethics and privacy laws and was conducted ethically following the World Medical Association Declaration of Helsinki. Furthermore, our IRB follows the International Guideline for Human Research protection as required by the Declaration of Helsinki, The Belmont Report,

CIOMS Guideline and the International Conference on Harmonization in Good Clinical
Practice (ICH-GCP).

CONSENT FOR PUBLICATION
All participants gave written informed consent before participating in this study.

AVAILABILITY OF DATA AND MATERIALS
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; The dataset generated during and/or analyzed during the current study will be available from the corresponding author (M.M.) upon reasonable request and once the dataset has been fully exploited by the authors.

FUNDING
There was no specific funding for this specific study.

Conflict of interest
The authors have no conflict of interest with any commercial or other association connected with the submitted article. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022.  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 27, 2022. ; https://doi.org/10.1101/2022.04.25.22274251 doi: medRxiv preprint Table 1: Socio-demographic and biomarkers data of controls and Long COVID (LC) patients divided into two groups one with highly increased body temperature, lowered SpO2 and high nitro-oxidative stress (LC+O&NS) versus another group with fewer changes in these biomarkers (LC).

Figure 6
Results of cluster analysis with the formation of a new endophenotype class of patients with Long COVID (cluster 2) which is characterized by increased PBT (peak body temperature) and lowered peripheral oxygen saturation (SpO2) during acute COVID-19, and lowered zinc, Gpx (glutathione peroxidase) and TAC (total antioxidant capacity), and increased MDA (malondialdehyde), MPO (myeloperoxidase), NO (nitric oxide), PC (protein carbonyls), OSTOX/ANTIOX (oxidative stress toxicity / antioxidant defenses) ratio, CRP (C-reactive protein) and severity of the physio-affective phenome three to four months after the acute phase (Long COVID).